Pentobarbital is a short-acting barbiturate with sedative, anesthetic and anticonvulsant properties. Its use as a routine veterinary general anesthetic has declined, but it remains relevant in selected laboratory-animal procedures, refractory seizure treatment and authorized euthanasia formulations. The clinical effect changes with exposure, from sedation to profound central nervous system depression.
Group
Barbiturate anesthetic
Mechanism of Action
Pentobarbital enhances GABA-A-receptor-mediated inhibitory neurotransmission, principally by prolonging chloride-channel opening. At higher concentrations it produces broader central depression, including effects on excitatory signaling and direct channel activity. Reduced neuronal excitability explains anticonvulsant and anesthetic effects. At euthanasia exposure, profound depression leads to loss of consciousness followed by respiratory and cardiovascular arrest.
Dose Rates
Dogs
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| General anesthesia | 25–30 mg/kg | IV | Once | Titrate to effect, with respiratory support available. |
| Anesthetic infusion — Loading | 2–15 mg/kg | IV | Once | Titrate before starting maintenance infusion. |
| Anesthetic infusion — Maintenance | 0.2–1 mg/kg/hour | IV | Continuous | |
| Status epilepticus | 2–6 mg/kg | IV | As needed | Allow 15-20 minutes for full response before reassessment. |
| Euthanasia | 87 mg/kg | IV | Once | Euthanasia only. Approximate pentobarbital amount described for 390 mg/mL euthanasia solution at 1 mL/4.5 kg. Dedicated combination products must retain their full composition. |
| Sedation | 2–4 mg/kg | IV | ||
| Sedation | 2–4 mg/kg | PO | Every 6 h | |
| Ventilator chemical restraint | 1–3 mg/kg/hour | IV | Continuous | |
| General anesthesia | 10–30 mg/kg | IV | Once | Titrate to effect. |
| General anesthesia | 24–33 mg/kg | IV | Once | Titrate to effect. |
| Refractory seizure motor suppression | 3–15 mg/kg | IV | Heavy CNS depression may suppress movement without abolishing cerebral seizure activity; ventilation may be required. | |
| Refractory seizure motor suppression | 2–15 mg/kg | IV | Heavy CNS depression may suppress movement without abolishing cerebral seizure activity; ventilation may be required. |
Cats
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| General anesthesia | 25–30 mg/kg | IV | Once | Titrate to effect, with respiratory support available. |
| Anesthetic infusion — Loading | 2–15 mg/kg | IV | Once | Titrate before starting maintenance infusion. |
| Anesthetic infusion — Maintenance | 0.2–1 mg/kg/hour | IV | Continuous | |
| Status epilepticus | 2–6 mg/kg | IV | As needed | Allow 15-20 minutes for full response before reassessment. |
| Euthanasia | 87 mg/kg | IV | Once | Euthanasia only. Approximate pentobarbital amount described for 390 mg/mL euthanasia solution at 1 mL/4.5 kg. Dedicated combination products must retain their full composition. |
| Sedation | 2–4 mg/kg | IV | ||
| Sedation | 2–4 mg/kg | PO | Every 6 h | |
| Ventilator chemical restraint | 1–3 mg/kg/hour | IV | Continuous | |
| Status epilepticus | 5–15 mg/kg | IV | To effect. | |
| Status epilepticus | 3–15 mg/kg | IV | Every 4–8 h | Slow administration; target heavy sedation. |
| General anesthesia | 25 mg/kg | IV | Once | Additional 10 mg/kg IV reported if induction inadequate. |
Cattle
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Standing sedation | 1–2 mg/kg | IV | Once | |
| General anesthesia | 20–30 mg/kg | IV | Once | Administer to effect. |
| Chlorinated hydrocarbon toxicosis adjunct | 30 mg/kg | IV | As needed | Titrate to effect. |
| Calf anesthesia | 15–30 mg/kg | IV | Calves over 1 month of age. | |
| Standing sedation fixed alternative | 1–2 g/animal | IV | Adult cow; titrate until unsteady. Approximately 3 g may cause recumbency. |
Sheep
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| General anesthesia | 20–30 mg/kg | IV | Once | Administer to effect. |
| Adult anesthesia | 11–54 mg/kg | IV | Average reported amount 24 mg/kg; duration affects need for supplementation. | |
| Lamb anesthesia | 15–26 mg/kg | IV | An additional 5.5 mg/kg IV reportedly extends anesthesia by about 30 minutes. |
Goat
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| General anesthesia | 20–30 mg/kg | IV | Once | Administer to effect. |
| General anesthesia | 25 mg/kg | IV | Slowly; reported satisfactory duration about 20 minutes. |
Mice
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Chemical restraint or anesthesia | 30–80 mg/kg | IP | Once |
Rats
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Chemical restraint or anesthesia | 40–60 mg/kg | IP | Once |
Hamsters
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Chemical restraint or anesthesia | 70–80 mg/kg | IP | Once |
Gerbils
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Chemical restraint or anesthesia | 70–80 mg/kg | IP | Once |
Guinea pigs
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Chemical restraint or anesthesia | 15–40 mg/kg | IP | Once | |
| Chemical restraint or anesthesia | 30 mg/kg | IV | Once |
Rabbits
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Chemical restraint or anesthesia | 20–60 mg/kg | IV | Once |
Pigs
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Chemical restraint or anesthesia | 15–30 mg/kg | IV | Once |
Horses
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Chemical restraint or anesthesia | 3–15 mg/kg | IV | Once | Adult equine excitement/recovery injury makes this a less suitable agent. |
| Chemical restraint or anesthesia | 15–18 mg/kg | IV | Once | Adult equine excitement/recovery injury makes this a less suitable agent. |
Indications
- General anesthesia or chemical restraint in selected veterinary or laboratory-animal procedures.
- Specialist control of refractory status epilepticus or severe toxin-associated convulsions within a supported critical-care protocol.
- Veterinary euthanasia using an authorized preparation and procedure.
Contraindications
- Rapid IV injection can cause fatal apnea; narrow therapeutic index.
Interactions
- Other anesthetics potentiate depression; hepatic enzyme inducers or inhibitors can alter clearance.
Adverse effects
- Respiratory and cardiovascular depression.
Toxicity
Overdose causes respiratory arrest and cardiovascular collapse. Overdose causes coma, respiratory failure and cardiovascular collapse. Support airway and circulation; carcasses containing euthanasia drug can poison scavenging animals. Enhanced elimination may be considered in severe poisoning.
Preparations
| Preparation | Form | Strength | Route |
|---|---|---|---|
| Pentobarbital sodium anesthetic injection 50 mg/mL Anesthetic formulation; not an interchangeable euthanasia mixture. | Injection | 50 mg / mL | IV |
| Pentobarbital sodium anesthetic injection 65 mg/mL Anesthetic formulation; not an interchangeable euthanasia mixture. | Injection | 65 mg / mL | IV |
Monitoring and Administration
Provide airway support and monitor ventilation, pulse and rhythm. For anesthesia, give about half the calculated amount first and titrate the remainder.
Alkaline injection precipitates with acidic/hydrochloride drugs. Euthanized carcasses retain pentobarbital and must be kept from scavengers.
Ventilator restraint may involve separate opioid or benzodiazepine infusions. Long recovery and seizure-like movements may complicate weaning; a shorter-acting agent can be substituted before ventilator withdrawal.